Lucid Diagnostics Inc (LUCD) 13F Ownership Report (Q2 2026)

LUCD ranks #4225 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

118 institutions disclose a position in LUCD, but none treat it as a major bet — even Perkins Capital Management Inc, its most concentrated holder, allocates just 0.9% of its own portfolio to it.

BlackRock has added to its LUCD position for two straight quarters, increasing it by $4.3M to reach $9.0M today.

Jim Simons has trimmed its LUCD position for two straight quarters, cutting it by $824.6K while still holding $76.3K.

LUCD is up 0.7% today, and institutions have been net buyers of $30.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

LUCD reported a net loss of $52.3M over the trailing twelve months.

• Not yet profitable — net loss of $52.3M over the trailing twelve months
• Revenue grew 5.0% year over year
• Net income improved year over year, from -$55.3M to -$52.3M
• Operating cash flow was negative, using $46.5M in cash
• Current ratio of 1.31x — below the conventional 1.5x liquidity buffer
• Liabilities run 2.70x equity — a highly leveraged balance sheet worth noting